Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Issues
2011
December 2011, Vol 2, No 7
December 2011, Vol 2, No 7
Predictive Biomarker for Bevacizumab May Be Emerging
By
Audrey Andrews
ESMO 2011 Conference
,
ESMO
December 2011, Vol 2, No 7
Read Article
Medical Staff Members Spend Many Hours Dealing with Insurance Companies
By
Caroline Helwick
Health Policy
,
Policies & Guidelines
December 2011, Vol 2, No 7
Medical practices in the United States spend much more money and time dealing with third-party payers than do Canadian practices, according to a recent report (Morra D, et al. Health Aff. 2011;30:1443-1450).
Read Article
SWOG: Two Hormonal Agents Extend Survival over Anastrozole Alone in Metastatic Breast Cancer
By
Caroline Helwick
CTRC-AACR SABCS Annual Meeting
December 2011, Vol 2, No 7
;Two antiestrogen agents may be better than one in the treatment of metastatic hormone receptor-positive breast cancer patients, according to a study conducted by the Southwest Oncology Group (SWOG) clinical trials network and presented at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium.
Read Article
New Prognostic Tool to Guide Treatment of Ductal Carcinoma In Situ
By
Caroline Helwick
CTRC-AACR SABCS Annual Meeting
December 2011, Vol 2, No 7
Read Article
Adding Everolimus to Exemestane Significantly Prolongs Remission in Patients with Breast Cancer
By
Caroline Helwick
CTRC-AACR SABCS Annual Meeting
December 2011, Vol 2, No 7
Read Article
Role of Adjuvant Zoledronic Acid in Endocrine Receptor-Positive Breast Cancer Being Refined
By
Phoebe Starr
CTRC-AACR SABCS Annual Meeting
December 2011, Vol 2, No 7
Read Article
FDA Updates OS Label Data for Bortezomib in Myeloma
FDA Approvals, News & Updates
December 2011, Vol 2, No 7
Read Article
Cetuximab Gains New Indication for Metastatic Head/Neck Cancer
FDA Approvals, News & Updates
December 2011, Vol 2, No 7
Read Article
Ruxolitinib First Drug Indicated for Myelofibrosis
FDA Approvals, News & Updates
December 2011, Vol 2, No 7
Read Article
Asparaginase Erwinia chrysanthemi for ALL
FDA Approvals, News & Updates
December 2011, Vol 2, No 7
Read Article
Page 2 of 4
1
2
3
4
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Medication Assurance Programs, as Deceiving and Harmful as Alternate Funding Programs
Dawn Holcombe, MBA, FACMPE, ACHE
2.
Addressing Challenges to Adoption of Value-Based Agreements
Phoebe Starr
3.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma